Cite
HARVARD Citation
Chen, J. et al. (2015). Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease. Bioorganic & medicinal chemistry letters. 25 (4), pp. 767-774. [Online].